Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe

  Bladder Cancer

  Free Subscription


1 Am J Pathol
1 Cancer Biother Radiopharm
1 Cancer Immunol Immunother
1 Cancer Sci
1 Cancers (Basel)
1 DNA Cell Biol
1 Eur J Oncol Nurs
2 Eur Urol
1 Eur Urol Oncol
1 Exp Ther Med
1 Future Oncol
2 In Vivo
1 J Endourol
1 J Geriatr Oncol
1 J Int Med Res
1 Mol Carcinog
1 Mol Pharm
1 Retina
1 Sensors (Basel)
1 Strahlenther Onkol
1 Turk J Med Sci
1 Urol J
1 Urol Oncol
2 World J Urol
1 Zhonghua Yi Xue Za Zhi

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Pathol

  1. MASUDA N, Murakami K, Kita Y, Hamada A, et al
    Trp53 mutation in Krt5-expressing basal cells facilitates the development of basal squamous-like invasive bladder cancer in the chemical carcinogenesis of mouse bladder.
    Am J Pathol. 2020 Apr 24. pii: S0002-9440(20)30202.
    PubMed         Abstract available

    Cancer Biother Radiopharm

  2. CUI Y, Xie M, Zhang Z
    LINC00958 Involves in Bladder Cancer Through Sponging miR-378a-3p to Elevate IGF1R.
    Cancer Biother Radiopharm. 2020 Apr 28. doi: 10.1089/cbr.2019.3300.
    PubMed         Abstract available

    Cancer Immunol Immunother

  3. JAZAYERI MH, Aghaie T, Nedaeinia R, Manian M, et al
    Rapid noninvasive detection of bladder cancer using survivin antibody-conjugated gold nanoparticles (GNPs) based on localized surface plasmon resonance (LSPR).
    Cancer Immunol Immunother. 2020 Apr 30. pii: 10.1007/s00262-020-02559.
    PubMed         Abstract available

    Cancer Sci

  4. LIU S, Chen L, Zhao H, Li Q, et al
    Integrin beta8 facilitates tumor growth and drug resistance via a YBX1 dependent signaling pathway in bladder cancer.
    Cancer Sci. 2020 Apr 29. doi: 10.1111/cas.14439.
    PubMed         Abstract available

    Cancers (Basel)

  5. MONTEIRO-REIS S, Lameirinhas A, Miranda-Goncalves V, Felizardo D, et al
    Sirtuins' Deregulation in Bladder Cancer: SIRT7 Is Implicated in Tumor Progression through Epithelial to Mesenchymal Transition Promotion.
    Cancers (Basel). 2020;12.
    PubMed         Abstract available

    DNA Cell Biol

  6. GAO L, Meng J, Zhang M, Fan S, et al
    Expression and Prognostic Values of the Roof Plate-Specific Spondin Family in Bladder Cancer.
    DNA Cell Biol. 2020 Apr 29. doi: 10.1089/dna.2019.5224.
    PubMed         Abstract available

    Eur J Oncol Nurs

  7. HEYES SM, Bond MJ
    Pathways to psychological wellbeing for patients with bladder cancer and their partners-in-care.
    Eur J Oncol Nurs. 2020;46:101757.
    PubMed         Abstract available

    Eur Urol

  8. WOERL AC, Eckstein M, Geiger J, Wagner DC, et al
    Deep Learning Predicts Molecular Subtype of Muscle-invasive Bladder Cancer from Conventional Histopathological Slides.
    Eur Urol. 2020 Apr 27. pii: S0302-2838(20)30255.
    PubMed         Abstract available

  9. LOUIS L, Thomas S, Yohann L, Morgan R, et al
    Adjustments in the Use of Intravesical Instillations of Bacillus Calmette-Guerin for High-risk Non-muscle-invasive Bladder Cancer During the COVID-19 Pandemic.
    Eur Urol. 2020 Apr 24. pii: S0302-2838(20)30302.
    PubMed         Abstract available

    Eur Urol Oncol

  10. PEDERZOLI F, Ferrarese R, Amato V, Locatelli I, et al
    Sex-specific Alterations in the Urinary and Tissue Microbiome in Therapy-naive Urothelial Bladder Cancer Patients.
    Eur Urol Oncol. 2020 Apr 25. pii: S2588-9311(20)30050.
    PubMed         Abstract available

    Exp Ther Med

  11. LIU Q, Zhou Q, Zhong P
    circ_0067934 increases bladder cancer cell proliferation, migration and invasion through suppressing miR-1304 expression and increasing Myc expression levels.
    Exp Ther Med. 2020;19:3751-3759.
    PubMed         Abstract available

    Future Oncol

  12. THAM SM, Mahendran R, Chiong E, Wu QH, et al
    Gmcsf and Ifnalpha gene therapy improves the response to BCG immunotherapy in a murine model of bladder cancer.
    Future Oncol. 2020 Apr 30. doi: 10.2217/fon-2020-0137.
    PubMed         Abstract available

    In Vivo

  13. RADES D, Nguyen T, Schild SE
    The Results of Whole-brain Radiotherapy for Elderly Patients With Brain Metastases from Urinary Bladder Cancer.
    In Vivo. 2020;34:1317-1320.
    PubMed         Abstract available

  14. TAMURA K, Watanabe K, Matsushita Y, Watanabe H, et al
    Enhanced Sensitivity to NVP-BEZ235 by Inhibition of p62/SQSTM1 in Human Bladder Cancer KoTCC-1 Cells Both In Vitro and In Vivo.
    In Vivo. 2020;34:1001-1008.
    PubMed         Abstract available

    J Endourol

  15. KRAJEWSKI W, Nowak L, Poletajew S, Tukiendorf A, et al
    The Impact of Restaging Transurethral Resection of Bladder Tumour on Survival Parameters in T1 Non-Muscle Invasive Bladder Cancer - Systematic Review and Meta-analysis.
    J Endourol. 2020 Apr 25. doi: 10.1089/end.2020.0301.
    PubMed         Abstract available

    J Geriatr Oncol

  16. JAZZAR U, Shan Y, Klaassen Z, Freedland SJ, et al
    Impact of Alzheimer's disease and related dementia diagnosis following treatment for bladder cancer.
    J Geriatr Oncol. 2020 Apr 27. pii: S1879-4068(20)30061.
    PubMed         Abstract available

    J Int Med Res

  17. QUAN X, Qin Q, Chen Y, Wei Y, et al
    Independent risk factors and the potential predictors of bladder cancer-related ischemic stroke.
    J Int Med Res. 2020;48:300060520919227.

    Mol Carcinog

  18. GUO Z, Zhu H, Xu W, Wang X, et al
    Alternative splicing related genetic variants contribute to bladder cancer risk.
    Mol Carcinog. 2020 Apr 27. doi: 10.1002/mc.23207.
    PubMed         Abstract available

    Mol Pharm

  19. PEREIRA PMR, Parada B, Ribeiro-Rodrigues TM, Fontes-Ribeiro CA, et al
    Caveolin-1 modulation increases efficacy of a galacto-conjugated phthalocyanine in bladder cancer cells resistant to photodynamic therapy.
    Mol Pharm. 2020 Apr 27. doi: 10.1021/acs.molpharmaceut.0c00298.
    PubMed         Abstract available


  20. LESHNO A, Vishnevskia-Dai V, Barak A, Zur D, et al
    Retina. 2017 Dec 15. doi: 10.1097/IAE.0000000000001998.
    PubMed         Abstract available

    Sensors (Basel)

  21. STEFAN-VAN STADEN RI, Gheorghe DC, Jinga V, Sima CS, et al
    Fast Screening of Whole Blood and Tumor Tissue for Bladder Cancer Biomarkers Using Stochastic Needle Sensors.
    Sensors (Basel). 2020;20.
    PubMed         Abstract available

    Strahlenther Onkol

  22. DUNST J
    [Organ-preserving treatment of bladder cancer].
    Strahlenther Onkol. 2020 Apr 27. pii: 10.1007/s00066-020-01608.

    Turk J Med Sci

    Molecular Subtyping Bladder Cancer: Is it ready for clinical practice?
    Turk J Med Sci. 2020 Apr 27. doi: 10.3906/sag-2004.
    PubMed         Abstract available

    Urol J

  24. SANDOUGHDARAN S, Razzaghdoust A, Tabibi A, Basiri A, et al
    Randomized, Double-blind Pilot Study of Nanocurcumin in Bladder Cancer Patients Receiving Induction Chemotherapy.
    Urol J. 2020 Apr 30. pii: 5719/1477. doi: 10.22037/uj.v0i0.5719.
    PubMed         Abstract available

    Urol Oncol

    Commentary on characterization of urinary microbiome in patients with bladder cancer: Results from a single-institution, feasibility study.
    Urol Oncol. 2020 Apr 24. pii: S1078-1439(20)30137.

    World J Urol

  26. TEOH JYC, Roupret M, Shariat SF, Herrmann T, et al
    Intravesical therapy for bladder cancer in the pandemic of Covid-19.
    World J Urol. 2020 Apr 30. pii: 10.1007/s00345-020-03218.

  27. AFFERI L, Zamboni S, Karnes RJ, Roghmann F, et al
    The impact of treatment modality on survival in patients with clinical node-positive bladder cancer: results from a multicenter collaboration.
    World J Urol. 2020 Apr 30. pii: 10.1007/s00345-020-03205.
    PubMed         Abstract available

    Zhonghua Yi Xue Za Zhi

  28. XIANG H, Liu Z, Zhou YB, Yao Q, et al
    [Effects of long non-coding RNA FLJ37505 on the proliferation and migration of bladder cancer cells].
    Zhonghua Yi Xue Za Zhi. 2020;100:1249-1254.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.